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Abstract 
The clinical standard method of measurement for clinical visual sensitivity is currently Standard 
Automated Perimetry with a size III target (SAP III). However, there are many factors that can make 
the results unreliable. While there is literature that confirms the benefit of increasing target size for 
measurement of visual sensitivity in the later stages of glaucoma, there is little literature that looks into 
the effect of increasing target size for the measurement of visual sensitivity in early glaucoma. 
Furthermore, the effect of increasing target size for the measurement of visual sensitivity in normals is 
largely undefined. We performed 2 studies to determine the effect of increasing target size for the 
perimetric measurement of both normals and in participants with very early glaucoma. 
In the first study (chapter 2), 40 normal participants (one study eye) performed 3 full threshold 
visual fields at 2 separate visits, no more than 90 days apart. The target sizes used were size III (0.43° 
diameter), size V (1.72° diameter) and size VI (3.44° diameter). We investigated the interaction of the 
different target sizes by regressing the average field threshold for each participant against age in both 
decibels and candelas. We found an expected difference in sensitivities between the different target 
sizes for the decibel analysis, but an unexpected difference in thresholds between the target sizes for 
the candela analysis. Possible reasons for this unexpected difference in total light energy are discussed.  
In the second study (chapter 3) we investigated the effect of increasing target size in 17 
participants with very early glaucoma (perimetric mean deviation of equal to, or better than, -4.0dB). 
Each participant underwent 3 full threshold visual field tests, using 3 different target sizes, at 2 
separate visits (no more than 90 days apart). We computed empirical probability plots for each 
participant and target size: Size III (0.43° diameter), size V (1.72° diameter) and size VI (3.44° 
diameter), where normal percentile limits were based on the first study - chapter 2. We then compared 
the number of normal and abnormal test locations at each defect depth (5%, 2%, 1% and 0.5%) 
between SITA-Std and the 3 different target sizes (full threshold) using a repeated measures ANOVA. 
We found there to be no statistical difference in the number of abnormal locations detected between 
SITA-Std and the 3 target sizes. However, when analysing the empirical probability plots there was an 
apparent clinical difference between the locations of abnormality detected between SITA-Std and the 
larger size VI target, with the size VI giving less consistent defect locations. 
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Chapter 1: Literature Review 
 
1.1 Glaucoma 
 Glaucoma, the world’s second most prevalent cause of blindness1, is an umbrella term for a range of 
progressive ocular diseases. The definition of the glaucomas has changed over the years, with a current 
definition being that it is a range of diseases that arise as a result of various risk factors, including 
increased intraocular pressure (IOP), with a common consequence of optic neuropathy and ultimately, 
loss of visual sensitivity
2
. The types of glaucoma are many, but almost all occur in the older 
generations and can include primary open angle glaucoma, secondary open angle glaucoma, including 
pigmentary glaucoma and pseudoexfoliation glaucoma, and primary or secondary closed angle 
glaucoma. Due to the high prevalence of the glaucomas and the severe visual consequences, it is 
important that progression of this disease can be monitored accurately, so that treatment can be 
administered and adjusted effectively.  
 
1.2 Structure and Function  
In the literature, the evidence for a structure-function relationship when measuring defect in glaucoma 
is much debated. Harwerth et al.
3
 investigated the correlation between structural and functional 
measurements of retinal ganglion cells (RGCs) and their axons in adult rhesus monkeys, both for the 
normal population and monkeys that were laser treated to scar their trabecular meshwork and induce 
high IOP (experimental glaucoma). When the functional Standard Automated Perimetry (SAP) 
measurements and the structural Optical Coherence Tomography (OCT) measurements were 
converted to a shared parameter of RGC populations, the measurements were correlated for both the 
controls and the experimental glaucoma populations. They suggested that, to accurately gauge the 
correlation between retinal function and structure measurements, there should be a common 
denominator, such as RGC population, to compare the 2 methods of neural loss. Furthermore, they 
proposed that the discrepancy between function and structure measurements in other studies could be 
due to the lack of sensitivity of many of the instruments that measure either parameter: It is thought 
that OCT is much more sensitive to detecting the small, early RGC changes, whereas SAP is more apt 
for detecting gross defects in advanced glaucoma due to its large clinically useful range (dynamic 
range)
3
. In 2010, Harwerth et al.
4
 further explored these concepts and proposed a model that could 
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estimate with reasonable precision the neural loss from both visual sensitivity measurements and 
retinal nerve fibre layer (RNFL) thickness in patients with glaucoma using time domain OCT and 
SAP. However, the authors did state that the relationship should be reconsidered using newer 
technology to measure the RNFL thickness, such as a spectral domain OCT (SD-OCT), to increase the 
accuracy and precision of the model.  
More recently, another study
5
 showed that there is a weak linear relationship between 
structural and functional damage, even in suspect/early glaucoma, when comparing visual sensitivity 
measured by SAP and rim area (RA) measured by Cirrus high definition spectral domain optical 
coherence technology (Cirrus HD-OCT; Carl Zeiss Meditec, Dublin, CA, USA). Optic disc RA 
measurement appeared to have a stronger correlation to SAP measurements than RNFL thickness in 
this study. To second the study by Nilforushan et al., Leite et al.
6
 used very similar instruments (Cirrus 
SD-OCT and SAP) to show that there was a linear correlation with a weak –moderate strength of 
relationship (r
2
 = 0.203) between structural and functional damage in early/suspected glaucoma 
patients when perimetric sensitivity was converted to a linear scale. The authors suggested that, had 
they also included patients with advanced glaucoma, the results may have shown a much stronger 
correlation. This comment was based on the results of a relatively recent study which found a stronger 
structure/ function correlation when including a proportion of more advanced glaucoma participants
7.
 
There have, however, been studies to suggest that structural damage in glaucoma precedes 
functional damage
8-10
. Sommer et al.
8
 suggested that 60% of glaucomatous eyes showed RNFL 
damage before visual field loss. However, these results are difficult to compare with previous studies 
as their results relied upon 2 examiners measuring both the functional and structural loss with a 
Goldmann perimeter and a Zeiss fundus camera respectively. In essence, this study relied heavily on 
the experience of the examiners. A later study by Matsumoto et al.
9
showed, by a more objective 
method, that RNFL thickness was already decreased in participants with glaucoma before visual 
sensitivity became reduced when using the Humphrey Field Analyzer (HFA) and an updated version 
of the Nerve Fiber Analyzer (NFA, GDx Version 1.012) to measure visual field loss and RNFL 
thickness respectively. However, this study only measured patients with primary open angle glaucoma 
(POAG) and normal tension glaucoma (NTG), so did not encompass the full range of the glaucomas. 
Interestingly, another recent study evidenced that not all types of optic disc damage resulting from 
glaucoma exhibit the same rate of structural or functional progression
11
. This study showed that 
patients with focal optic disc damage have a more rapid decline in visual field loss and optic disc 
change than other types of optic disc damage, such as diffuse or sclerotic optic disc damage. However, 
  3 
despite a more rapid structural and functional loss in focal disc damage, only the functional loss was 
shown to be statistically significant
11
. The results of this study highlight that all types of glaucoma 
should be included in the study sample to gain a non-biased result across the range of glaucomas. The 
lack of structure-function correlation found in a proportion of the literature could also be due to the 
lack of a common denominator when comparing the variables, as proposed by Harwerth et al.
3
.  
However, despite the discrepancy in the literature, there are studies which present evidence 
that functional damage is correlated with structural glaucomatous damage
4, 5, 7
, although the 
conclusions that are drawn depend on the precision and accuracy of the instruments used to measure 
both structural and functional damage and a common denominator to link the two variables being 
measured 
3
. In short, although there is still debate as to the exact relationship, functional damage is 
known to be correlated with structural damage in glaucoma. For this reason, it is important that 
functional progression is monitored accurately at all stages of the disease. 
 
1.3 Measuring Functional Loss in Glaucoma 
Visual sensitivity, measured by a perimeter, has been, and still is, the clinical standard for evaluating 
functional progression of the disease. More specifically, Standard Automated Perimetry with a white 
Goldmann size III target (SAP III) presented on a white background is the current clinical standard 
when measuring functional defects in glaucoma. SAP III has been shown to be a compromise between 
blur 
12
, accuracy of result 
13
 obtained and effective dynamic range (EDR)
14
. An early study
13
 showed 
that smaller targets measure absolute scotomas more accurately. In this study the blindspot, used as an 
absolute scotoma, was measured with Goldmann stimuli I through V. They demonstrated that larger 
targets measured the blindspot as more relative and less defined than smaller targets and attributed this 
to the increasing light scatter with the larger targets. They suggested that, as a greater amount of light 
(i.e. larger stimulus) passed through the optic media of the eye, there was increased scattering of the 
target, creating a larger halo of light. In normal eyes, lateral inhibition would eliminate these haloes. 
However, this mechanism is not active at borders of seeing/non-seeing retina (i.e. scotomas). The 
authors’ conclusion was that, when detecting scotomas that are small in spatial area, the smallest target 
size possible should be used. While Anderson et al. also agreed that smaller targets gave a more 
accurate measurement of scotomas; they determined that larger targets were less influenced by dioptric 
blur in uncorrected peripheral refractive error
12
. One other advantage of using a larger target is that 
EDR increases with increasing target size
14
. Therefore, SAP III is a compromise between maximising 
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EDR, optimising accuracy of defect detection and dioptric blur effects and is currently used as the 
clinical standard to measure visual sensitivity in both healthy patients and in ocular pathology, such as 
glaucoma. 
However, when measuring visual sensitivity by means of a perimeter, there has been much 
research into factors that can cause the results to be unreliable. More recent literature that has revisited 









, foveal and peripheral dioptric blur
12
, level of instruction 
given
20
 and both short term
21
 and long term fluctuation
22
. In addition, due to the limited number of 
stimuli presented at each location in the interests of a maintaining a test that is of reasonable length, 
the staircase threshold method may possibly measure inaccurate results. One other main concern is 
that variability with SAP III is shown to be high in areas of retinal pathology
22, 23
 resulting in poor 
accuracy when monitoring progression of visual sensitivity in these areas
24
. An early study by Heijl et 
al.
23
, measuring perimetric test/re-test variation in 51 patients with glaucoma using SAP III, showed 
that variation is a product of both defect depth and eccentricity. For participants with initial visual 
field loss in the range of approximately -8 to -18dB, the 95% prediction interval of re-test thresholds 
varied across almost the whole extent of possible sensitivities. Furthermore, with shallower defect 
depth, variation increased as a factor of eccentricity. In light of these results, the authors concluded 
that the greater the retinal damage, the larger the test/ re-test variation, although they also showed that 
variation in much greater abnormality reduces. Furthermore, in areas of shallow defect depth, variation 
is greater in the peripheral field. A recent study
22
 that looked at long term fluctuation (LF) in 
Humphrey Field Analyser (HFA) SITA standard perimetric testing across different stages of glaucoma 
(classified using the GSS2 scale), confirmed this early study by Heijl et al., showing that LF increased 
up to stage 4 in a curvilinear fashion. Interestingly, at stage 5, they also found a decrease in LF and 
suggested this could be due to the scotomas presenting in more advanced glaucoma being much more 
absolute and less relative, showing less fluctuation. These results by Fogagnolo et al. do show that LF 
becomes, in general, greater as glaucoma progresses. Henson
25
, using frequency of seeing curves to 
measure perimetric intra-test variability, also concluded that variability increases with decreasing 
retinal sensitivity. With these findings in mind, it is vitally important that ways are found to decrease 
the variability of results in these damaged retinal areas to enable an accurate prediction of disease 
progression within glaucoma.  
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1.4 Increasing Target Size 
There have already been promising results from studies that have, in recent years, revisited the effect 
of target size on perimetric variability, suggesting that increasing target size in SAP decreases 
variability in areas of manifest retinal disease
26-28
. One study showed that, when testing 10 normal 
participants using an HFA perimeter with Goldmann target sizes I - V, the size IV and V stimuli 
resulted in a reduced short term fluctuation while the smaller targets (size I and II) had an increased 
short term and total fluctuation
21
. The authors did, however, state that as their study did not include 
any patients with glaucoma or elderly patients, further investigation would be needed to determine if 
these results held true for these additional groups. In 1997, Wall and colleagues began a series of 
investigations looking at the effect of target size on perimetric results in patients with glaucoma
14, 26-30
. 
Their first study in this series
26
 investigated how increasing target size in automated perimetry affected 
perimetric variability in patients with well established POAG. They showed, using frequency of seeing 
curves, that the standard deviations of intra-test variability were significantly reduced for the size V 
target compared to size III or size I target for patients with glaucoma at abnormal test locations. This 
study, however, was carried out under quite artificial test conditions that did not mimic real life. Each 
patient was only tested in 2 test locations (controls: central and peripheral locations; glaucoma 
patients: normal and abnormal locations), with 205 stimulus presentations varying in stepwise 
threshold at each location. A more recent study by Wall et al.
28
 tested 120 patients with glaucoma 
(encompassing a range of severities) and 60 age-matched controls with 3 different perimeters (the 
HFA perimeter was utilized once with a size III target and once with a size V target). This 
investigation showed that re-test variability with the perimeters which employed larger target sizes 
was lower in areas of reduced sensitivity than those that employed smaller target sizes. Matrix 
perimetry (target size of 4°diameter) and motion perimetry (range of target sizes between 0.1 and 8° 
diameter), showed no clinically meaningful increased variability in areas of decreased sensitivity, such 
as that of both SAP measurements. Furthermore, SAP V (with a target size of 1.72 °diameter) showed 
reduced variability in areas of lower sensitivity compared to SAP III (with a target size of 0.43 
°diameter). A later study also promoted the use of SAP V by showing that the EDR for SAP V is 
about 1 log unit greater than that of SAP III
14
. There is also evidence for a similar precision of testing 
between the 2 target sizes when monitoring moderate glaucoma
27
. In 2013, Wall et al. continued this 
research, investigating the effect of a target size V over a target size III on variability of mean defect
29
. 
They found that there was only small decrease in variability of mean defect with size V target 
compared to a size III target. Nevertheless, these results serve to add to, not take-away from, the 
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evidence that is gathering to indicate that SAP V would be more accurate in detecting functional loss 
in moderate/established glaucoma, compared to SAP III
14, 26-28
. To take the research one step further, 
Wall et al. also looked at the performance of target size VI compared to size V and III
30
. When 
comparing the amount of abnormal test locations for a group of 120 glaucoma participants 
(encompassing all stages of the disease) between the 3 different target sizes, they found that the size V 
target was the most sensitive. When stratified into MD bins, the size V target was still the most 
sensitive for the lower MD bins, while size VI was the least sensitive. This suggests that there is a cut-
off point where a further increase in stimulus size can be detrimental to the perimetric results.   
 There is also evidence in the literature that enhanced perimetry results with increasing target 
size is not confined to SAP, but has been demonstrated in other types of perimetry. Quaid and 
Flanagan
31
 used normal participants to show that, with flicker defined form perimetry (FDF), as 
stimulus size increased, variability within subjects decreased and sensitivity increased at all 
eccentricities. In their 2009 study, Wall et al.
28
 showed decreased variability, not only with SAP V 
compared to SAP III, but with the increased target size in matrix and motion perimetry in areas of 
retinal defect in participants with glaucoma. The results from the literature described here show 
promise that, regardless of perimetric method, increasing target size could be the key to obtaining 
more repeatable perimetry results, especially in retinal areas that have been subject to neuronal 
damage.  
 There is certainly evidence to suggest that a larger size V target could be beneficial in 
measuring retinal sensitivity more accurately across the progression of glaucoma
14, 26-29
, and early 
evidence to suggest that increasing the target size to a size VI may be detrimental to detection of 
perimetric abnormality in disease
30
. However, the current literature looks at these effects across all 
stages of the disease, with a focus on moderate to established glaucoma. This research must be 
stretched further to investigate the effect of increasing target size on very early glaucoma. 
 
1.5 Spatial Summation 
Spatial summation is the summing of information over space. In the case of the retina, light energy 
over a certain area will be combined
40
. Spatial summation occurs across the retina and increases 
relative to the size of receptive fields with increasing eccentricity. Ricco’s Law states that, within each 
critical area (Ricco’s Area), as threshold intensity doubles, size of the target halves to maintain the 
quanta of energy reaching the retina
32
. As target size increases above the critical area incomplete 
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summation occurs, relative to Piper’s Law32. Ricco’s area is dependent on the size of receptive fields 
in the retina, and has been shown to enlarge with increasing retinal eccentricity for both s-cones and l-
cones when each type of cone was isolated and tested for foveal and peripheral spatial summation 
characteristics. The authors suggested that this was due to larger receptive fields and more 
convergence of photoreceptors in the periphery
33
 and suggested it is likely that Ricco’s area is dictated 
by density of RGCs in each area of the retina, explaining why Ricco’s area increases with increasing 
retinal eccentricity. 
 Interestingly, it has been shown that, in infants, a greater extent of visual field is measured 
with a 6° diameter target, compared to a 1.5° diameter target34. These results did not hold true for 
healthy adults though, and one reason for the difference was suggested to be due to infants having 
larger spatial summation properties in the peripheral retina compared to adults. These findings could 
be very relevant when measuring the visual field of participants with glaucoma, especially since 
spatial summation is a characteristic that has been shown to change in patients with glaucoma
35
. If 
differing spatial summation properties can affect the measurement of visual fields in infants
34
, then the 
measurement of visual sensitivity in patients with glaucoma could also be adapted if there exists 
changes in spatial summation properties in the ocular disease.  
 There is also evidence in the literature to support changes in Ricco’s area with age, although 
this literature is conflicting. The outcome of one early study showed that there was no change in 
spatial summation across different age groups
36
. The results of this study were limited, however, since 
spatial summation was only measured along the superior temporal oblique meridian in all participants. 
A much more recent study investigating the full extent of the human retina, shows that the density of 
neurones in the retina declines per year, although this effect is much more pronounced when 
considering the entire retina than it is in the foveal regions
37
. This conclusion is consistent with the 
findings of Malania et al. in 2011, who also broadened their study to look at the effect of RGC loss on 
spatial summation
38
. These authors showed that spatial summation increased with age in the 
parafoveal area, due to loss of RGCs. While they explained the significant parafoveal increase in 
spatial summation of the older participants by a related loss of RGCs, they justified the preserved 
spatial summation properties in the fovea by the minimal age-related loss of RGCs in the foveal region 
of the retina. 
Bearing this in mind, it is also thought that there could be alterations in receptive fields and 
spatial summation properties as a result of the progressive loss of RGCs in glaucoma
35
, although there 
is literature that rejects this theory
39
. Battista et al.
39
 investigated how spatial summation differed 
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across the magnocellular (M) and parvocellular (P) pathways, and also between controls and patients 
with primary open angle glaucoma (POAG). Although this study did show that spatial summation 
characteristics differ across the M and P pathways, the elevation in threshold with differing stimulus 
size when measured in controls and POAG subjects was not significant. The authors did, however, 
acknowledge that if they had used a wider range of stimulus sizes they may have obtained a different 
result. Redmond et al.
35
 undertook an experiment to monitor how Ricco’s area and spatial summation 
changes within the early stages of glaucoma. By comparing healthy subjects to patients with early 
glaucoma, they showed that there was a significant increase in size of Riccos’ area for achromatic and 
s-cone specific stimuli in the early glaucoma participants. They concluded that Ricco’s area becomes 
enlarged even at the early stages of the disease and suggested this may be a result of each receptive 
field needing a critical number of RGC to enable the stimulus to be detected. It was also suggested by 
these authors, that increasing target size in relation to the enlargement of Ricco’s area in patients with 
glaucoma would be beneficial in encompassing areas with a greater number of healthy RGCs, despite 
inevitable glaucomatous loss of RGC. This result, however, is confined to early glaucoma and has not 
yet been proven in the later stages of the disease. Further study needs to be carried out in this area to 
confirm these results, but these initial studies show promise that increased areas of spatial summation 
in early glaucoma could serve as a means of explaining the reason for more accurate perimetry results 
with larger stimulus sizes when measuring functional loss in glaucoma. 
 
1.6 Summary and Conclusion 
In conclusion, there is evidence to show that increasing target size from Goldmann size III to 
Goldmann size V decreases perimetric variability in both normals
21
 and patients with moderate to 
advanced glaucoma
26, 28
. Furthermore, EDR is also greater with a size V target
14
. It is possible that 
decreased variability with increasing target size can be attributed to the spatial summation properties 
changing with progression of glaucoma
35
. Volbrecht et al.
33
 suggested that spatial summation 
properties change with loss of RGCs to maintain a constant density of neurones within the critical 
area, which could explain this phenomenon. 
Despite these findings, SAP III is currently used as the clinical standard to measure visual 
sensitivity, and there is evidence to show that use of larger target sizes reduces the detection accuracy 
of relative scotomas
13
. Since early functional change in glaucoma presents as relative scotomas and 
this research has mainly focused on patients with moderate to advanced glaucoma, there needs to be 
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further study at looking into whether increasing target size in early glaucoma is beneficial in 





The Effect of Increasing Target Size on the Measurement of Visual 
Sensitivity in Normals: Defining Normal Limits 
Sarah L. Bishop, Yuan-Hao (Derek) Ho, John G. Flanagan 
2.1 Overview 
Purpose: To investigate the effect of increasing perimetric target size for the measurement of visual 
sensitivity in normals. 
Methods: Forty normal participants were recruited and 3 visual fields were performed on one study 
eye at 2 separate visits, no more than 90 days apart. The target sizes used were size III (0.43° 
diameter), size V (1.72° diameter) and size VI (3.44° diameter).We investigated the interaction of the 
different target sizes by regressing the average field threshold for each participant against age in both 
decibels and candelas. 
Results: We found an expected difference in sensitivities between the different target sizes for the 
decibel analysis, but an unexpected difference in thresholds between the target sizes for the candela 
analysis (total light energy). When values were converted back to size III dBs, the minimum fitted 
threshold difference in total light energy was 4.68dB and the maximum fitted threshold difference was 
11.65dB  
Conclusions: We suggest that the difference in total light energy between the 3 different target sizes 
was mainly due to changing properties of retinal spatial summation with many factors. 
2.2 Introduction 
Standard Automated Perimetry (SAP) with a Goldmann size III target (0.43° diameter) is the clinical 
standard method for measuring visual sensitivity. It has been regarded as the clinical standard method 
after a series of research papers showed it to be a compromise between the influences of dioptric blur 
(larger stimuli better)
12
, accuracy of result (smaller stimuli better)
13
 and effective dynamic range 
(EDR) (larger stimuli better)
14
. However, even the gold standard size III target can be unreliable. 
There are many factors that can cause perimetric results to be unreliable: some physiological (pupil 
size
17, 18
 and media opacities
19





foveal and peripheral dioptric blur
12
, level of instruction given
20
 and both short term
21
 and long term 
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fluctuation
22
). In addition, there is a very real concern around increasing variability of perimetric 
results as defect depth deepens in patients with glaucoma
23
. 
In light of this, there have been a number of studies that have recently revisited the 





. It is thought that spatial summation properties apply when altering target size to 
determine visual sensitivity. For a stimulus that falls within a receptive field up to 10minutes of arc, 
the light energy is summed, complete spatial summation occurs and Ricco’s Law applies: As target 
size doubles, the light energy halves to maintain a constant total amount of light energy
32
. As the target 
size increases to an area greater than that which will fall within the retinal receptive field, incomplete 
spatial summation occurs, where the product of the target area to a coefficient value of k (0 < k< 1) 
and target luminance maintains a constant total amount of light energy. The value of the coefficient k 
varies with the degree of spatial summation. This theory is the basis of Goldmann’s Law of constancy, 
which is applied in perimetry and is important when looking at the effect of increasing target size in 
perimetry.  
When investigating the effect of perimetric target size on healthy participants, larger targets 
(size IV – 0.86° diameter and V – 1.72° diameter) showed less short term fluctuation, but a similar 
long term fluctuation to the size III target
21
. The authors suggested, therefore, that there would be no 
benefit in changing target size from the gold standard size III target. However, this was a small study, 
with a sample of 10 participants and the authors did acknowledge the limitations of the young average 
age of their study participants (29.1 ± 6.1yrs). There have also been a series of studies that have shown 
there to be benefits to increasing target size when measuring perimetric threshold in patients with 
moderate to advanced glaucoma
14, 26-28
. These benefits include increased effective dynamic range 
(EDR)
14
 and reduced variability in areas of greater defect depth
26, 28
 coupled with a similar precision of 
testing between target size III and target size V
27
. Recently, the research was extended to look at the 
effect of a size VI target (3.44°diameter), compared to a size V and III target across the range of 
glaucoma severities
30
. The results of this study found the target size V to be most sensitive with size 
VI being the least sensitive to detecting abnormality. 
It is important now to look in greater detail at how increasing target size affects perimetric 
measurement in controls, extending the research to include a greater number of participants and a 
wider age-range.  
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2.3 Methods 
2.3.1 Participants 
We tested one eye of 40 healthy participants, recruited from the School of Optometry and Vision 
Science, University of Waterloo, Canada. The participants, which were stratified by age (10 year 
bands), had a mean age of 58.9 years and ranged from 41 to 76 years. Eighteen participants were male 
and 22 participants were female. All participants underwent baseline measurements on both eyes and 
ocular health screening to ensure they were eligible to be included in the study. These measurements 
included: Visual acuity, refraction (if needed), perimetric testing using a Humphrey Field Analyzer 
SITA-Std 24-2 test, optical coherence tomography using the Cirrus Optical Coherence Tomographer; 
Carl Zeiss Meditec, intraocular pressure measurement by Goldmann applanation tonometry and a 
fundus photograph.  Participants were included if the study eye had a refractive error equal to or less 
than 5DS and 2.50DC with a best corrected visual acuity of 6/9 or better. They were excluded if they 
had any history of ocular surgery, or trauma, or any ocular/ systemic disease that could affect the 
visual field outcome in the study eye. They were also excluded if they had a diagnosis of amblyopia in 
the non-study eye. If both eyes were eligible for the study, the right eye of odd-numbered participants 
and the left eye of even-numbered participants were enrolled. 
2.3.2 Visual Testing 
Since all participants were naïve perimetry observers, each participant attended 2 study visits, no more 
than 90 days apart. The first visit served as a practise visit where the participants were familiarized 
with the visual field testing in order to mitigate learning effects. At each visit, 3 perimetric tests, each 
with a different target size, were carried out on the study eye using appropriate near refractive 
correction as defined by the perimeter. All perimetric testing was carried out using Standard 
Automated Perimetry, 24-2 full threshold with the Humphrey Field Analyzer (HFA; Carl Zeiss 
Meditec). The stimulus sizes used for the 3 tests at each visit were Goldmann stimulus size III (0.43° 
diameter, 4mm
2
), size V (1.72° diameter, 64mm
2
) and size VI (3.44° diameter, 256mm
2
) respectively. 
The order of the visual field tests was randomised for each participant, but maintained for the second 
study visit. A minimum rest break of 5 minutes was given between tests. Tests were repeated if the 
false positive rate was greater than or equal to 15%. In addition, 3-dimensional imaging of the optic 
disc and macula was performed using the Cirrus high definition optical coherence tomographer (Cirrus 
HD-OCT; Carl Zeiss Meditec) for both eyes on the first visit and the study eye on the second visit. 
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2.3.3 Statistical Analysis 
As the first visit was a practise session, we analysed only the second visit perimetry results for each 
target size. We removed all blindspot locations (co-ordinates (15,3) and (15,-3) for OD and (-15,3) and 
(-15,-3) for OS) and, at the locations where 2 threshold readings were measured, we used the second 
measurement. To assess the interaction between the 3 different target sizes, we took each participant’s 
average threshold (over the entire field in decibels) and converted the value to candelas (measurements 





 to candelas (cd) – equations in appendixA). This conversion was carried out in order 
to obtain a linear scale and total light energy for each target size, eliminating spatial summation 
effects. We then regressed these average thresholds (in both dB and cd) against age for each target size 
To compare the difference in total light energy between the target sizes, we took the minimum and 
maximum fitted difference between the target sizes in cd and converted the values back to size III dB 
to give a meaningful value. 
2.4 Results 
When measured in dB, figure 2-4-1 shows that, as target size increased, average threshold also 
increased (light intensity decreased). Based on spatial summation properties and Goldmann’s law of 
constancy, we would anticipate that, when converted to total light energy (threshold in cd), the 
luminous intensity for each target size would be equivalent. However, figure 2-4-2 shows that as target 
size increased, total light energy also increased. Table 1 outlines the minimum and maximum average 
fitted threshold differences, calculated in size III dB, between each target size when the thresholds 
were converted to cd (values based on robust fit). The threshold difference varied between 4.68 and 
11.65 size III dBs. The largest difference was between the size III and size VI target, but there was a 
noticeable difference between all fitted values. Additionally, when the data was plotted by concentric 
zone for the 3 target sizes (central 10°, 10-16° and 16-24° ), figure 2-4-4 shows that this trend held true 
within each concentric zone. Furthermore, figure 2-4-2 shows that the difference between average 
fitted thresholds (total light energy in cd) increases with age, especially for the size VI target. When 
fitted by age, figure 2-4-3 shows that, up to the age of 65 yrs, the fitted threshold difference in cd (total 
light energy) between the 3 target sizes was linear. As age increased above 65yrs, we can see that there 
was a stepwise increase in average threshold for all 3 target sizes. When using a robust fit, the 
difference in total light energy was still constant between target size III and V, but there was a slight 
increase in fitted difference as age increased between target size III and VI and target sizes V and VI 
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 When comparing inter-individual variation, the size III target showed the greatest inter-
individual variation when average threshold was measured in dB (figure 2-4-1). However, when 
converted to total light energy (threshold in cd), the size III target had the least inter-individual 
variation and the size VI target showed the greatest inter-individual variation (figure 2-4-2). Size V 
inter-individual variation was similar when measured in dB and when converted to cd. 
 Finally, we also measured the actual size of each of the targets as displayed in the HFA (table 
2). We found all the stimuli to be very slightly smaller than the expected area. This decrease in area 
was between 3.02% and 5.04% smaller than the expected measurement. 
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Figure 2-4-1: Graph to show comparison of full field average perimetric sensitivities for size III, 
V and VI targets in decibels 
 
 
Figure 2-4-2: Graph to show comparison of full field average perimetric thresholds for size III, 
V and VI targets in candelas (regular fitting; dotted line, robust fitting; solid line) 
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Figure 2-4-3: Graph to show optimal linear fits of full field average perimetric thresholds for 
size III, V and VI targets in candelas for the both participants under 65yrs , and over 65yrs 
(regular fitting; dotted line, robust fitting; solid line) 
 
Figure 2-4-4a: Graph to show comparison of average concentric zone perimetric threshold for 
III, V and VI targets in candelas 
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Figure 2-4-4b: Graph to show robust fitting for the comparison of average concentric zone 
perimetric threshold for III, V and VI targets in candelas 
 
 
 Target sizes Difference (in size III dB) 
Difference @ 41yrs of age III to V 5.96 
III to VI 11.25 
V to VI 5.28 
Difference @ 76yrs of age III to V 6.97 
III to VI 11.65 
V to VI 4.68 
Table 1: Table corresponding to figure 2-4-2 to show the difference, in size III dBs, between the 
robust fitting for each target size taken at 41 yrs and at 76 yrs where the difference was 
minimum and maximum, respectively, in cd. 
 



































Target size III Target size V Target size VI 
Projected  Actual (mean 
average of 3, 
 % decrease 
from expected) 
Projected  Actual (mean 
average of 3, 
 % decrease 
from expected) 
Projected  Actual (mean 
average of 3, 
 % decrease 
from expected)  
4 3.81, 4.75 64 60.77, 5.04 256 248.26, 3.02 
Table 2: Table to show the expected and actual measurements of the HFA target sizes on the 
HFA perimeter that we used for the study 
2.5 Discussion 
When considering average full field perimetric threshold in dB, our study shows that as target size 
increased, stimulus intensity decreased (figure 2-4-1). These results seem to agree with the spatial 
summation theory (Ricco’s Law of energy conservation)32. However, when these values were 
converted to total light energy (threshold in cd), thus removing the effects of spatial summation, we 
found there to be an increase in average threshold value (figure 2-4-2). We are aware that the dB 
threshold values can only be as accurate as 0.5dB due to the increment step size of the HFA. This 
0.5dB value varies over the range of light intensities once converted to a linear scale. However, at 




which is a considerably smaller value than any difference 
between fitted values in figure 2-4-2. Therefore, we can ascertain that there is an actual difference 
between the light intensities of the different target sizes, even when removing the effects of spatial 
summation. 
 We can speculate on the reasons that these differences in total light intensities may occur 
between target sizes. Firstly there are potential errors that may cause this discrepancy between the 
values: Calibration of the HFA may have initially been miscalculated, or the apertures in the target 
wheel may have been misjudged at production. In this case, we would expect the size V and VI 
apertures to be too small (participants would be observing the light to be too bright – the smaller the 
aperture the brighter the target would be seen due to the spatial summation theory). When measuring 
the actual stimulus sizes, as displayed by the HFA, we found the target sizes to be only very slightly 
smaller than expected (values in table 2). Since the size differences between expected and actual are 
minimal, and since the size III target was also slightly too small, this in itself cannot wholly account 
for the difference in total light energy we found between the target sizes. Furthermore, we also found a 
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slightly greater difference in the total light energy with increasing age between the size III and V target 
and the size III and VI target (figure 2-4-2). Figure 2-4-3 shows that there was a stepwise increase in 
average threshold as age increased to 65yrs. This suggests a further reasoning behind the difference 
between target sizes. 
Another explanation could be due to the characteristics of spatial summation, and therefore, 
Goldmann’s theory of energy conservation, changing across the retina. Goldmann perimetry, where 
Goldmann’s law of energy conservation was originally formed is a kinetic perimetry test measuring 
visual sensitivity of the peripheral retina. Conversely, the HFA-FT perimetry testing we used in this 
study is a static perimetry test and only measures the central 24° of the visual field.  
 We know that in some areas of the retina there is complete spatial summation (when a 
stimulus of less than 10 minutes of arc falls directly in a receptive field). However, when the stimulus 
exceeds the size of the receptive field, incomplete spatial summation occurs
32
. Goldmann’s Law of 
energy conservation applied in perimetric testing is defined by the following equation:  
A
k
 x L= C 
Where: A= area of target (mm
2
); k= coefficient between 0 and 1 indicating whether spatial summation 
is complete or incomplete (dependent on many factors), where 1= complete spatial summation and 0= 
incomplete spatial summation; L=luminance of target (asb); C=constant 
40
 
The accepted value of k for perimetric testing is a constant value of 0.8. However, we know 
that the degree of spatial summation changes with many factors, thus in reality, the value of the 
coefficient k is far from constant. It is known that the extent of spatial summation changes with 
eccentricity
36
. Dannheim also confirmed that the value of k changes as target size differs. Furthermore, 
across individuals, the shape of the spatial summation curves change, showing that the value of k not 
only differs within individuals, but also between individuals
36
. Another paper demonstrated a change 
in spatial summation properties in the parafoveal retinal area, likely explained by age-related loss of 
retinal ganglion cells and subsequent re-organisation of the receptive fields
38
. Since our study 
encompassed both change in target size and many participants of the older generation, it is highly 
likely that the value of the coefficient k differed not only across participants, but also within 
participants. This in itself could have caused the unexpected difference in total light energy between 
target sizes.  
If we take the current value of the coefficient k used for the size III target to be correct (where 
k=0.8), we can calculate the expected values of k for the size V and VI targets, based on an expected, 
known area for each stimulus. This can be calculated for age below 65yrs (since, when converted to 
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cd, we know that the threshold step change in cd is constant between the 3 different target sizes, thus 
the value of k will also be constant across this age range within target size). Using the fitted threshold 
values, where threshold is measured with a linear scale (asb), and applying Goldmann’s Law of 
Energy Conservation (p21), the following k values are established: For the size V target, k = 0.6, for 
the size VI target, k = 0.5. Where age increases above 65yrs, k is clearly affected to a greater degree 
and with an inconsistent step change. 
Conversely, if we take the value of the coefficient k to be 0.8 and assume that it is correct 
across all target sizes, we can calculate the resulting area of target sizes (if the size III target is taken to 
be 4mm
2
). Using Goldmann’s law of energy conservation (on p21), the following areas are 
established: Size V target = 21.5mm
2
, Size VI target = 29.1mm
2
. 
Therefore, if the value of k was taken to be correct at 0.8 across all target sizes, and the 
difference in total light energy was due to engineering/calibration error, the size of the stimuli would 
have to be a great deal smaller to compensate (as shown above). Since the actual areas of all the 
stimuli were only slightly smaller than the expected measurements (table 2), the difference in total 
light energy we found between the 3 different target sizes is likely mainly due to the changing value of 
the coefficient k across target sizes. The reality that all the stimuli are very slightly too small (and to a 
very similar degree) could account for an overall increase in total light energy, but could not account 
for the overall difference between the target sizes. 
The difference in inter-individual threshold variability found between target sizes in this study 
is also interesting. Gilpin et al.
21
 looked at the effect of increasing target size on perimetric variability, 
although thresholds were only analysed in dB. They found larger target sizes (size V and VI) to have 
greater inter-individual variation. In our study, we found target sizes V and VI to have lower inter-
individual variability when measured in dB (figure 2-4-1), but size VI to have the largest inter-
individual variation when measured in cd (figure 2-4-2). The difference between our findings and 
Gilpin et al’s results is likely due to Gilpin’s study being performed on a smaller sample of younger 
participants.  We also found target size V to have the most stable inter-individual variability when 
thresholds are converted from dB to cd. 
Based on our results, target size V seems to have benefits over the gold standard target size III 
when used to measure visual sensitivity in normals, since it has the lowest inter-individual variability 
when thresholds are measured in dB and converted to total light energy (cd). However, SAP III is the 
current gold standard method of perimetry measurement due to it being a compromise between the 
influences of dioptric blur
12
, accuracy of result
13
 and effective dynamic range (EDR)
14
 and the value of 
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the coefficient k is based upon these gold standard conditions (currently taken as k=0.8). However, 
since we know that the value of k changes both between and within participants as factors such as age 
and target size vary, there must be further work to verify the adjustment needed for k as these factors 
change to ensure equality of total light energy across the targets sizes.  
In summary, our research shows that increasing target size does not give equality of results, 
even when converted to total light energy and this inequality increases as age increases above 65yrs. If 
the target sizes are accurately calibrated then it is likely due to the changing value of the coefficient k 
(determinant of the completeness of spatial summation in any given situation). The stimuli being 
slightly too small may also account for some overall increase total light energy. Therefore, before 
another target size is deemed as a rival for the current gold standard, there must be further research to 
ensure the stimuli are accurately calibrated and verify the optimum value of k for each stimulus size, 
by eccentricity and age. 
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Chapter 3 
The Effect of Increasing Target Size on the Detection of 
Abnormality in Very Early Glaucoma 
Sarah L. Bishop, Natalie Hutchings, John G. Flanagan 
3.1 Overview 
Purpose: To investigate the effect of increasing target size on the measurement of visual sensitivity 
in very early glaucoma.  
Methods: Seventeen participants with very early glaucoma (perimetric mean deviation of equal to, or 
better than, -4.0dB) were recruited and 3 full threshold visual field tests were performed on one 
study eye of each participant using 3 different target sizes, at 2 separate visits (no more than 90 days 
apart). We compared the normal and abnormal test locations between SITA-Std and the full 
threshold target sizes III (0.43° diameter), V (1.72° diameter) and VI (3.44° diameter) by computing 
empirical probability plots for each participant and target size (normal percentile limits defined from 
normal data in chapter 2). We then compared the number of normal and abnormal test locations at 
each defect depth (5%, 2%, 1% and 0.5%) between SITA-Std and the 3 different target sizes using 
repeated measures analysis of variance. 
Results: We found there to be no notable difference in amount or location of defect between SITA-
Std and the size III full threshold perimetric testing, confirming equivalence in the tests. We also 
found there to be no difference in number of abnormal points between SITA-Std and the 3 different 
target sizes (p = 0.066). However, the locations of abnormal points for the largest size VI target were 
not found to be correlated well with those of SITA-Std. 
Conclusions: Our results suggested that, although there was statistically no difference in the number 
of abnormal points detected with the larger target sizes, the size VI target was not as sensitive as 
SITA-Std due to a discrepancy between the locations of abnormal points detected. 
3.2 Introduction 
Functional progression of glaucoma, across all stages, is routinely monitored by using the Standard 
Automated Perimetry, size III target (SAP III – 0.43° diameter, 4mm2). This is the gold standard 
perimetric measurement, since it was shown to be a compromise between the effects of peripheral 
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dioptric blur
12
, accuracy of result
13
 and effective dynamic range (EDR)
14
. However, there is literature 
that shows perimetric accuracy with a size III target to decrease notably as defect depth increases
22, 
23
. In light of this, there have been a number of research papers that have investigated ways to 
increase the accuracy and precision when measuring functional defect in glaucoma. Recently, the 
relationship between increasing target size and measurement of visual fields has been re-examined in 
participants with glaucoma. This literature has shown many benefits to increasing target size up to a 
size V target (1.72° diameter, 64mm2). These benefits include decreased variability as defect depth 
increases
26, 28
 and greater EDR
14
. There is also literature showing the precision of testing to be 
similar between the gold standard size Goldmann III target and the larger Goldmann size V target
27
. 
Recently a paper looked at the effect of a size V and VI Goldmann (3.44° diameter, 256mm2) target 
on the measurement of visual fields in participants with all stages of glaucoma
30
. This research 
showed that target size V had a slightly better sensitivity to detecting abnormality in glaucoma 
patients, both across the range of severities and in relatively early defect.  
When using Goldmann target sizes, Goldmann’s Law of constancy is applied (based on 
Ricco’s Law of spatial summation): Within a given area below 10 (Ricco’s area), the total light 
energy needed to produce a response (area to the power of a coefficient k multiplied by luminance) 
is constant
40
. The value of the coefficient k varies between 0 and 1, depending on the degree of 
spatial summation. Ricco’s area has been shown to increase in the periphery of a healthy retina for 
both s-cones and l-cones
33
. The literature also suggests that Ricco’s area increases, due to loss of 
retinal ganglion cells, (RGCs) in both age
38
 and in glaucoma
35
, to maintain a similar number of 
RGCs in a receptive field. Redmond et al.
35
 suggested that the larger targets are able to still fall 
within Ricco’s area and be detected by a greater number of ‘healthy’ RGCs, resulting in a more 
reliable result with a larger target size.  
Increasing target size has largely been shown to be of benefit when measuring visual 
sensitivity in glaucoma
14, 26-28
, although there is question as to whether increasing further to a size VI 
is detrimental to the sensitivity of the perimetric test
30
. However, previous research has mostly been 
performed using participants with moderate to late stage glaucoma, and must be extended to looking 
at the very early stage of the disease. This study will investigate the effect of target size III, V and VI 
on the measurement of visual sensitivity in the very earliest stages of glaucoma. 
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3.3 Methods 
3.3.1 Participants 
One eye of 17 participants, with very early glaucoma, was tested. All types of glaucoma were 
included, as long as treatment had been started. These participants were recruited from the Ocular 
Health Clinic of the School of Optometry and Vision Sciences, University of Waterloo, Canada and 
from Optometry and Ophthalmology Offices in Kitchener-Waterloo, Ontario. The glaucoma 
participants had a mean average age of 63.2 years and ranged from 48 years to78 years. Nine 
participants were male and 8 participants were female. The participants were stratified into 4 groups 
according to mean deviation (MD), where MD was better than -2dB, measured by the Humphrey 
Field Analyzer (HFA; Carl Zeiss Meditec), with an additional MD group between -2dB and -4dB. In 
addition, participants were required to have a refractive error equal to or less than 5DS and 2.50DC 
with a best corrected visual acuity of 6/9 or better. They were excluded if they had any history of 
ocular surgery, or trauma, or any ocular/ systemic disease that could affect the visual field outcome, 
other than glaucoma, in the study eye, or a diagnosis of amblyopia in the non-study eye. All 
participants were experienced in perimetry testing. 
3.3.2 Visual Testing 
Each participant attended 2 study visits, where the first visit served as a practice to mitigate learning 
effects. The visits were no more than 90 days apart. At each visit, 3 perimetric tests, each with a 
different target size, were carried out using appropriate near refractive correction, as defined by the 
perimeter. All perimetric testing was carried out using Standard Automated Perimetry, 24-2 full 
threshold with the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec). The stimulus sizes used for 
the 3 tests at each visit were Goldmann stimulus size III (0.43° diameter, 4mm
2
), Goldmann size V 
(1.72° diameter, 64mm
2
) and Goldmann size VI (3.44° diameter, 256mm
2
) respectively. The order 
of the visual field tests was randomised for each participant, but maintained for the second visit. A 
minimum rest break of 5 minutes was given between tests. Tests were repeated if the false positive 
rate was greater than, or equal to, 15%. In addition, 3-dimensional imaging of the optic disc and 
macula was performed using the Cirrus high definition optical coherence tomographer (Cirrus HD-
OCT; Carl Zeiss Meditec) for both eyes on the first visit and the study eye on the second visit. 
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3.3.3 Statistical Analysis 
As the first visit was a practise session, we used the second visit perimetry results for each target 
size. All blindspot locations were removed (co-ordinates (15,3) and (15,-3) for OD and (-15,3) and (-
15,-3) for OS) and, at the locations where 2 threshold readings were measured, we used the second 
measurement. To establish the limits of normality for each full threshold target size we used normal 
data collected from 40 participants (Chapter 2) to determine percentile limits for each location (52 
locations) and target size (3 target sizes). We then plotted the thresholds for the participants with 
early glaucoma for each location (in decibels - dB). From these graphs, we determined normal and 
abnormal locations, taking defect depth into consideration, for every participant (n=17) and all 
stimulus sizes. We then computed empirical probability plots for all participants and all target sizes. 
We also compared the results to the SITA-Std plots obtained at recruitment. A repeated measures 
analysis of variance (rANOVA) was used to compare the number of normal and abnormal test 
locations detected by SITA-Std and each of the 3 target sizes at each defect depth across 
participants. 
3.4 Results 
Figure 3-4-1 (A-D) shows an example of the empirical probability plots computed to compare the 
normal and abnormal locations between SITA-Std and all target sizes for each participant (see 
Appendix for all plots). When comparing the probability plots of the SITA-Std and the 3 different 
full threshold Goldmann target sizes (target size III, size V, size VI), we found there to be no 
significant difference in the number of normal or abnormal test locations (5%, 2%, 1% and 0.5% 
deviations from normal) across target sizes (rANOVA; Target Size*Abnormality F(12, 240)=1.708, 
p=0.066; Figure 3-4-2). The empirical probability plots also show that SITA-Std and the size III full 
threshold detected defects in similar locations for each participant, since 78% of the time (mean 
average; range of 63% to 96%), both size III perimetric tests detected equivalent locations as normal 
or abnormal for a single participant (see figure 3-4-3). Since there was no difference between the 
number of normal and abnormal locations detected, and since these locations are similar, we can 
confirm that the SITA-Std database and the calculated full threshold size III tests are comparable.  
Although the statistical tests showed that there was no significant difference in the detection 
of visual sensitivity when using the larger target sizes compared to the current gold standard size III 
target, the empirical probability plots showed an important clinical observation that must be taken in 
to account. When comparing the distribution of abnormal locations across the visual field, SITA-Std 
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and size III full threshold detected similar abnormal locations (see figure 3-4-3). The size V target 
appeared to detect abnormal locations that were altogether similar to SITA-Std, although there were 
a few cases where the abnormal locations were not sufficiently comparable. When comparing the 
size VI target to SITA-Std, in some cases, the VI target detected more abnormal locations than 
SITA-Std (e.g. participants 211 and 216) and in some cases, the larger target detected less 
abnormality (e.g. participants 207 and 210). There were a few cases were size VI detected generally 
scattered points compared to SITA-Std (e.g. participants 203 and 214). Despite size VI detecting a 
similar number of abnormal locations statistically, when observing the empirical probability plots, 
the distribution of abnormal locations for the majority of participants was  inconsistent compared to 
the SITA-Std results (current clinical standard). Table 3 shows the 3 target sizes for each participant 
ranked in order of how similar each empirical probability plot appeared to SITA-Std. Overall, the 
size VI target showed the most inconsistency to the SITA-Std abnormal locations based on the 
ranking scores (table 3), while the full threshold size III and size V targets were, in comparison to 













Figure 3-4-1: Example of empirical probability plots showing good agreement between SITA-
Std and full threshold size III for participant 207 (OD) using: A: SITA-Std size III, .B: Full 
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 UW Size III
 UW Size V
 UW Size VI
Figure 3-4-2: Interaction of target size and defect depth across early glaucoma subjects 
(rANOVA Target Size*Abnormality). There was no significant difference between target sizes 




Figure 3-4-3: Bar graph to show percentage of equivalent and non-equivalent locations 
between SITA-Std and size III full threshold visual fields. Measured as equivalent if both fields 




































% of Equivalent Locations % of Non-equivalent Locations 
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Participant 
ID 
Ranked score of target size (based on similarity of abnormal locations to SITA-Std 
plot)  III V VI 
202 2 3 1 
203 1 2 3 
204 1 2 3 
205 2 1 3 
206 1 2 3 
207 1 2 3 
208 3 2 1 
209 2 1 3 
210 1 2 3 
211 1 2 3 
212 1 2 3 
213 3 1 3 
214 1 2 3 
216 2 1 3 
217 1 2 3 
218 3 2 1 
221 1 2 3 
Total score 27 31 45 
 
Table 3: Table to show the ranked scores, for how similar the empirical probability plot 
appeared in relation to SITA-Std (where 1 = most similar and 3=least similar), based on 
locations of abnormality, for each participant  
3.5 Discussion 
The full threshold size III test detected a similar number and location of normal and abnormal points 
to SITA-Std size III, confirming that these databases were essentially equivalent. Our results also 
suggested that the number of abnormal points detected was similar across SITA-Std and the full 
threshold size III, size V and size VI targets in the early glaucoma group. However, we can confirm 
that there was a clinical difference in the distribution of abnormal points between the SITA-Std and 
full threshold size VI target by observing the empirical probability plots. While the full threshold 
size III and size V targets detected a similar number of abnormal points, the size VI target was not 
always able to detect the extent of abnormality in these early glaucoma participants. Sometimes the 
size VI target also detected points that were much more scattered than the clinical standard.  
We know from previous literature that there are advantages to using a size V target to 
measure functional defect in moderate to advanced glaucoma; namely a larger EDR
14
, decreased 
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variability
26, 28
 and a slightly greater degree of repeatability when measuring perimetric mean 
deviation
29
. Wall et al also showed that there was a similar precision of testing between the size III 
and size V target for the later stages of glaucoma
27
. Our results suggest that there is also a similar 
precision of testing between a size III and size V target when measuring functional defect in the very 
early stages of glaucoma. 
We also determined the number of abnormal test locations detected in the very early 
glaucoma participants with a larger size VI target. Our results showed that, statistically, we 
identified a similar number of abnormal points with a size VI compared to a size V or size III target. 
These results suggested that there was no disadvantage to increasing target size even further. This, 
however, is surprising, since Bek
13
 showed the larger the stimulus, the more relative the scotoma 
measured. This difference in results could have been due to the fact that Bek used the blindspot as an 
absolute scotoma while we used participants with known visual field defects due to glaucoma. 
However, although statistically the size VI target seemed to detect a similar number of abnormal 
points as SITA-Std, the larger target size did not always accurately match the spatial location of 
SITA-Std and, therefore, was considered not as sensitive clinically as the current standard (table 3) 
as it may lead to a different interpretation of the visual field defect.  
Recently Wall et al.
30
 also investigated the effect of increasing target size to a size VI when 
measuring visual sensitivity in patients with a range of glaucoma severities, although the authors 
mainly focused on participants with moderate to advanced glaucoma. They found that full threshold 
perimetric testing with a size V target was the most sensitive to detecting visual loss in the glaucoma 
participants across the full range of severities. They also found that the larger size VI target was too 
large to detect the full extent of abnormality in these patients. They suggested that the lower 
sensitivity they found was due to the larger target sizes being partly viewed across the steep borders 
of the moderate/advanced glaucomatous scotomas. This theory could also explain the difference 
between our findings and the findings of Wall et al. when looking at the number of abnormal 
locations. All of our participants were included in the study as a result of their very early glaucoma 
(MD equal to, or better than, -4dB). In very early glaucoma the scotomas are generally much more 
relative and the borders are less steep. We suggest that, with the shallower borders it is possible that 
the size VI target is less likely to be viewed at these borders (i.e. no steep cut off point), which may 
cause the size VI target to be detected at the same number of spatial locations, or even overestimate 
the defect in very early glaucoma compared to SITA-Std (e.g. participants 211 and 216). Another 
possibility is that the visibility of the target would not be significantly impacted with the shallower 
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defect, leading to underestimation of the defect (e.g. participants 207 and 210). Additionally, 
because of the early defect in our study, some participants displayed functional visual sensitivity 
close to normal (e.g. participants 208 and 212). In this case, SITA-Std and the full threshold targets 
all measured isolated, spurious defects in different locations. This would lead to a similar number, 
but different locations of abnormal points being detected with each target size. 
Although we found that there was no statistical difference in the number of abnormal 
locations detected between the size III, V and VI targets, we can conclude that the size VI target was 
less able to detect abnormality accurately and precisely in very early glaucoma compared to the 
clinical standard.  
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Chapter 4: Conclusion 
The aim of our research was to investigate the effect of increasing target size on the perimetric results 
in both normals and in early glaucoma. Since there are no current normative limits for the larger target 
sizes V (1.72° diameter) and VI (3.44° diameter), we firstly used 40 normal participants (aged 40-
80yrs) to define normal percentile limits by age and eccentricity for all target sizes (III, V and VI). We 
used these limits to identify abnormality in the early glaucoma group. Subsequently, we computed 
empirical probability plots for each of the 17 early glaucoma participants and compared the amount of 
defect between SITA-Std and the 3 target sizes using a rANOVA. 
 We found there to be no significant difference between the number of abnormal points 
detected with SITA-Std and the 3 target sizes (p=0.066), suggesting that there is no disadvantage to 
using a larger target size to measure functional defect in very early glaucoma. We also showed that a 
similar number, depth and location of abnormal points were detected for SITA-Std and the full 
threshold size III perimetric test, confirming that these databases were similar (see appendix for all 
empirical plots and figure 3-4-3). The difference between our findings and those of Wall et al.
30
 may 
have been due to our larger sample of participants with very early glaucoma manifesting more relative 
scotomas, which either led to overestimation or underestimation the defect. The discrepancy also 
could have been due to the size VI target sometimes picking up more scattered abnormal points, 
falsely detecting these as abnormal. Although the size VI target detected a similar number of abnormal 
locations statistically, suggesting that the size VI was just as sensitive as the size III target, the 
distribution of abnormal locations had poor spatial agreement between the size VI and SITA-Std 
(current clinical standard) – see empirical plots in appendices and table 3. Despite the few cases where 
the abnormal locations were not sufficiently comparable to the SITA-Std abnormal locations with a 
size V target, comparable abnormal locations were ascertained with most participants. In addition, the 
size V target manifested the most stable variation when converted from dB to total light energy (cd) in 
normals, giving the target size another advantage. 
 In addition to defining the normal percentile limits and comparing the amount of abnormality 
in the very early glaucoma participants, we also investigated the threshold interaction of the 3 target 
sizes for normal patients by age. We found an expected difference (due to spatial summation 
properties), between the average thresholds when measured in decibels. However, when converted to 
total light energy (threshold in candelas), a difference in threshold between the target sizes remained 
(as target size increased, light intensity also increased). This difference was constant up to the age of 
65 yrs, but increased slightly as age increased over the age of 65yrs when comparing the size III and V 
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target to size VI. We suggest that this remaining difference between total light energy was mainly due 
to the changing degree of spatial summation, and therefore changing value of the coefficient of 
summation value (k). An overall increase in total light energy may also be partly due to the stimuli 
sizes on the HFA being slightly too small. There are many different variables that influence the spatial 
summation coefficient value of k, including age
38
, eccentricity and target size
36
. If the currently used 
value of k (0.8) is used taken as true for the size III target, and the HFA is calibrated correctly, we 
suggest, based on our results, that the size V target would require a k value of 0.6 and the size VI 
target would require a k value of 0.5. It is probable that the reality of a variable k value with these 
factors could cause a discrepancy in thresholds. 
 In summary, we found that, although it appears as though functional defects in very early 
glaucoma can be equally as well detected with the larger targets as with the current, smaller standard 
size III target, our results showed that the larger size VI target was not able to accurately detect early 
defect compared to the current clinical standard visual field measurement (SITA-Std). The size V 
target does show promise though, in manifesting a similar sensitivity to detecting abnormality, both in 
amount and location. Our research has also shown that the total light energy for larger stimuli is not 
equivalent to that of the clinical standard target. This is thought to be due to varying spatial summation 
factors and, therefore, a changing value of the coefficient k that is not currently taken into 
consideration. Before a larger target size is used routinely in practice, there must be further research to 
ensure the stimuli are accurately calibrated and verify the optimum value of k for each stimulus size, 
by eccentricity and age.  
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Chapter 5: Future Directions 
Our research has shown that the size V target (1.72° diameter) has a similar precision of testing to the 
gold standard size III target (0.43°diameter) , although the size VI target (3.44° diameter) is not 
sensitive enough to detect the location of abnormality accurately. A size V target has been suggested, 
in the literature, to be an enhanced method of measurement for visual sensitivity in moderate to 
advanced glaucoma due to its clinical properties of a larger EDR 
14
 and reduced variability in greater 
defect depth 
26, 28
. Although we have found a similar precision of testing with size III and size V 
targets in very early glaucoma, further research with a greater number of very early glaucoma 
participants must be carried out to further verify these conclusions. Additionally, it is worth 
considering that, although SITA-Std is the current gold standard method of measuring visual 
sensitivity, it is difficult to determine whether the few extra abnormal locations detected with the size 
V target convey a greater sensitivity or simply unwanted scatter. 
Currently, the coefficient of summation in perimetry is taken to be k=0.8. It is already known 





. Our research agrees with this, and has shown that total light energy with the 3 different 
target sizes is far from equal when k is taken as a constant value across the different conditions. If a 
variable target size is to be used as a perimetric tool in the future, the exact values of k must be known 
as per target size to ensure equality. We have speculated that, if k=0.8 with a size III target, when a 
size V target is used, k=0.6 and when a size VI target is used, k=0.5. These values must be 
investigated with a larger sample of normal participants in order to establish these values with greater 
precision.  




: Conversion of decibels to candelas:  
Decibels to apostilbs:  
asb= (4-dB/10)
log-1
 (derivation graph below) 





















Sensitivity (dB) = 40-10*log10(x)
 
Figure: Graph to derive the conversion equation of dB to asb when using the conversion values 










Candelas per square metre to candelas: 
42
 
Size III: cd = 0.000004 * cd/m
2 
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Size V = 0.000064 * cd/m
2 
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